NeuroVista


NeuroVista Corporation was founded in 2002 by Dr. Leonidas Iasemidis and Dr. Daniel DiLorenzo as an early-stage medical device company that specialized in the management and treatment of epilepsy, including a novel Seizure Advisory System.
Based in Seattle, Washington, NeuroVista was previously known as NeuroBionics Corporation, and subsequently went through six rounds of financing totaling $61.3M USD.
In 2010, Cyberonics announced that it had entered into technology agreements with NeuroVista.
NeuroVista shut down operations in 2013.